| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 11/12/2003 | CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme |
| 11/12/2003 | CN1127484C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 11/12/2003 | CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity |
| 11/12/2003 | CN1127350C Cyclosorin-containing soft capsule preparations |
| 11/12/2003 | CN1127347C Medicine for curing hyperosteogeny |
| 11/11/2003 | US6646149 Derivitives of spermine or its N12-t-butyl carbamate |
| 11/11/2003 | US6646143 Anticancer agents; skin disorders |
| 11/11/2003 | US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 11/11/2003 | US6646004 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| 11/11/2003 | US6645998 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 11/11/2003 | US6645991 αvβ3 integrin inhibitors |
| 11/11/2003 | US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases |
| 11/11/2003 | US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors |
| 11/11/2003 | US6645974 Androgen receptor modulators and methods for use thereof |
| 11/11/2003 | US6645950 Benzimidazole vascular damaging agents |
| 11/11/2003 | US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound |
| 11/11/2003 | US6645500 Method for down-regulating osteoprotegerin ligand activity |
| 11/11/2003 | US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein |
| 11/11/2003 | US6645485 Method of treating inflammation in the joints of a body |
| 11/11/2003 | US6645482 Sulfated proteoglycan; one or more of a hexosamine sulfate,a flavone, olive kernel extract, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of CRH, caffeine, and a polyamine. |
| 11/11/2003 | CA2290332C Optically pure androgen mediator |
| 11/06/2003 | WO2003091414A2 Adipocyte complement related protein zacrp8 |
| 11/06/2003 | WO2003091271A1 Alternatively spliced nucleic acid molecules |
| 11/06/2003 | WO2003091259A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 11/06/2003 | WO2003091258A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 11/06/2003 | WO2003091257A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 11/06/2003 | WO2003091251A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents |
| 11/06/2003 | WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 11/06/2003 | WO2003091242A1 Novel thiol derivative, process for producing the same and use thereof |
| 11/06/2003 | WO2003091239A1 Estrogen receptor modulators |
| 11/06/2003 | WO2003091229A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 11/06/2003 | WO2003091227A1 Tachykinin receptor antagonists |
| 11/06/2003 | WO2003091223A1 Pyrimidine derivative |
| 11/06/2003 | WO2003090912A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 11/06/2003 | WO2003090868A1 Method and apparatus for ultrasound treatment of connective tissue |
| 11/06/2003 | WO2003090766A1 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans |
| 11/06/2003 | WO2003090759A1 Difructose anhydride-containing composition and use thereof |
| 11/06/2003 | WO2003090752A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 11/06/2003 | WO2003090748A1 Use of compounds having ccr antagonism |
| 11/06/2003 | WO2003090743A1 Prevention and treatment of functional somatic disorders, including stress-related disorders |
| 11/06/2003 | WO2003090737A2 Methods and compositions for treatment of cancer pain |
| 11/06/2003 | WO2003076458A3 Selective dipeptide inhibitors of kallikrein |
| 11/06/2003 | WO2003075685A3 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 11/06/2003 | WO2003057166A3 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 11/06/2003 | WO2003035626A3 Azole derivatives and pharmaceutical compositions containing them |
| 11/06/2003 | WO2003031939A3 Protein modification and maintenance molecules |
| 11/06/2003 | WO2003027263A3 Proteins associated with cell growth, differentiation, and death |
| 11/06/2003 | WO2003018640A3 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 11/06/2003 | WO2003016270A3 Selective estrogen receptor modulators |
| 11/06/2003 | WO2003013420A3 Isoprenyl derivatives and their use in the treatment and prevention of osteoporosis and cardiovascular calcification |
| 11/06/2003 | WO2003009855A3 Organo-phosphorous compounds for activating gamma/delta t cells |
| 11/06/2003 | WO2003009804A3 Conformationally constrained parathyroid hormone (pth) analogs |
| 11/06/2003 | WO2003007686A3 Use of copper chelators to inhibit the inactivation of protein c |
| 11/06/2003 | WO2003005966A3 Topical medicine and process and apparatus for making same |
| 11/06/2003 | WO2002092773A3 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 11/06/2003 | WO2002072631A3 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 11/06/2003 | WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor |
| 11/06/2003 | WO2002066667A8 Glucosamine and method of making glucosamine from microbial biomass |
| 11/06/2003 | WO2002060900A8 Antagonists of mcp-1 function and methods of use thereof |
| 11/06/2003 | WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors |
| 11/06/2003 | WO2002034204A3 Calcilytic compounds |
| 11/06/2003 | WO2002026737A8 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| 11/06/2003 | WO2002024891A9 B7-like molecules and uses thereof |
| 11/06/2003 | US20030208079 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for proph7ylaxis of cardiovascular disorders |
| 11/06/2003 | US20030208067 Inhibitors of protein kinase for the treatment of disease |
| 11/06/2003 | US20030208058 B7-like polypeptides and polynucleotides |
| 11/06/2003 | US20030208046 Pseudo native chemical ligation |
| 11/06/2003 | US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 11/06/2003 | US20030207931 Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1h-1,2,4-triazole for the treatment of autoimmune diseases |
| 11/06/2003 | US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds |
| 11/06/2003 | US20030207906 Chemical compounds |
| 11/06/2003 | US20030207902 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 11/06/2003 | US20030207900 2-substituted amino-bicyclic pyridine and pyrimidine compounds; for treatment of inflammation, inflammatory bowel disease, Alzheimer's disease, Crohn's disease, multiple sclerosis and asthma |
| 11/06/2003 | US20030207897 Selective inhibitors of cyclooxygenase-2 |
| 11/06/2003 | US20030207896 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts |
| 11/06/2003 | US20030207893 Antihistamines such as (5-Chloro-1H-indol-2-yl)-(4-methyl-piperazin-1-yl)-methanone, used as antiinflammatory, antiarthritic or bronchodilator agents and/or immunology modulators |
| 11/06/2003 | US20030207879 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 11/06/2003 | US20030207870 Aryl ureas with angiogenisis inhibiting activity |
| 11/06/2003 | US20030207867 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers |
| 11/06/2003 | US20030207850 Hormone replacement therapy |
| 11/06/2003 | US20030207846 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 11/06/2003 | US20030207834 The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals. |
| 11/06/2003 | US20030207816 Inducing or enhancing chondrogenesis in vivo or in vitro. The method is performed by exposing the cells in vitro or in vivo to an extracellular matrix comprising of type I collagen, type II collagen or a mixture of type I collagen or type II |
| 11/06/2003 | US20030207807 A feline hepatocyte growth factor gene and a 15 base pairs-deleted feline hepatocyte growth factor gene. These genes encode the following protein (a) or (b): a protein having an amino acid sequence shown in SEQ ID NO: 2 or 4; and a protein |
| 11/06/2003 | US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders |
| 11/06/2003 | US20030207318 Kinesin-like motor protein |
| 11/06/2003 | US20030207263 Method of screening therapeutic agents |
| 11/06/2003 | US20030206963 Bone resorption suppressing agent |
| 11/06/2003 | US20030206954 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
| 11/06/2003 | US20030206898 Use of anti-TNFalpha antibodies and another drug |
| 11/06/2003 | US20030206861 Uses of diterpenoid triepoxides as an antiproliferative agent |
| 11/06/2003 | CA2484546A1 Methods and compositions for treatment of cancer pain |
| 11/06/2003 | CA2484067A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 11/06/2003 | CA2483515A1 Novel thiol derivative, method for producing the same and use thereof |
| 11/06/2003 | CA2483431A1 Alternatively spliced nucleic acid molecules |
| 11/06/2003 | CA2483336A1 Method and apparatus for ultrasound treatment of connective tissue |
| 11/06/2003 | CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 11/06/2003 | CA2483253A1 Use of compounds having ccr antagonism |
| 11/06/2003 | CA2483093A1 Use of milnacipran or a pharmaceutically acceptable salt thereof for treating chronic low back pain |
| 11/06/2003 | CA2483075A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |